Application Guidelines for the IMEG Travel Support FY2018

2017.10.25 ●News

Application Guidelines for the IMEG Travel Support Program FY2018, Kumamoto University



The Institute of Molecular Embryology and Genetics (IMEG) of Kumamoto University shares research results, technology, analysis techniques, and related information accumulated to date to research partners to build a strong collaborative research base as a joint usage/research center. To further facilitate these joint activities, we are proud to announce the opening of the FY2018 Travel Support Program. This program will provide travel assistance for collaborative research in and joint use of our advanced research facilities. Applications will open twice, with the first deadline falling in February of 2018. To support prompt initiation of collaborative research activities throughout the year, the second opening for a limited number of applications will be from April to December, or until program funding runs out.


Successful applicants will be provided access to the common equipment on the same footing as their host researcher in IMEG. These include a mass spectrometer (Thermo Fisher Q-Exactive), a high-speed sequencer (Life Technology IonProton, and Illumina Next Seq), a single cell PCR, an InCell Analyzer, an automatic in situ hybridization system, and others. The costs for using these items may be supported by adding the analysis expenses to the travel expenses. In principal, support for analysis costs should be up to 100,000 yen (maximum of 200,000 yen for special circumstances). Additionally, any expenses that exceed the amount of support will be billed to the host researcher so it is necessary to first obtain pre-approval from the host.


Regarding the use of the common equipment, please consult with the host researcher carefully before applying. Refer to the following URLs for more information.     (Online Facilities Booking)       (Liaison Laboratory Research Promotion Center)



1.Travel Expense Support Fields
A)Developmental Regulation
Aims to clarify the mechanisms of developmental/regenerative phenomena and the onset/defense mechanisms of human diseases from the molecular, cellular, and tissue levels. Includes: epigenetics, protein functions, cell communication mechanisms, DNA damage repair mechanisms, etc.
B)Stem Cell Research
Aims to develop the controlling mechanisms of ES cells/iPS cells/tissue stem cells/etc. for regenerative medicine. Includes: manipulation of various stem cells, differentiation control mechanisms, differentiated cell function, etc.
Aims to clarify the basic principles of controlling 3D organ formation. Includes: organization of organs making use of model organisms such as genetically modified mice.

*Interdisciplinary issues spanning multiple areas may also be considered.


2.Application Eligibility
A)Faculty members or researchers of a university or research institution in Japan or overseas as of 1 April 2018. Graduate students may not be research leaders but they can be members of the research team.


3.Supported Expenses
A)Support for travel expenses will be provided for visits (approximately 2 nights & 3 days per visit) necessary for collaborative research (domestic, up to 100,000 yen). This support may be used for multiple visits. In principal, up to 100,000 yen may be added to the travel expenses for analysis fees from the use of common laboratory equipment. Support for overseas researchers including both travel and analysis expenses will be up to 400,000 yen (max 500,000 yen for special circumstances) for collaborative research within this laboratory. Please be aware that there is a limit on the number of adopted applications.


4.Support Period and Application Deadlines
A)Support period: One year from 1 April 2018 to 31 March 2019

B)Application deadlines:1st Opening – 1 February 2018 (Thurs)
2nd Opening – 1 April to 31 December 2018

Applications are accepted throughout the designated period but recruitment may close when the number of adoptions reaches the planned limit.


5.Application Procedures
A)Researchers wishing to conduct collaborative research should contact the appropriate host faculty of IMEG before submitting an application.
B)Please convert the application form (Form 3) into PDF format and submit it as an email attachment. Set the subject of the email as “IMEG Collaborative Research Application (APPLICANT NAME)”.


<<Documents to be Submitted>>
2018 IMEG Travel Support Application Form (Form 3)
MS Word Format                       PDF Format



6.Application Submission
A)Administrative Division of Research Centers for Life Sciences
Kumamoto University
2-2-1 Honjo, Chuo-ku, Kumamoto City, 860-0811
TEL 096-373-6637 (domestic), +81-96-373-6637 (international)
FAX 096-373-6638 (domestic), +81-96-373-6638 (international)
E-mail iys-senter*
(Please replace the “*” with the “@” sign.)


7.Notification of Results
A)The applicant will be informed of a decision after deliberation by the IMEG Management Council.
B)Please note that Information about adopted applications (name of research leader, name of affiliated organization, research subject) will be posted on the website of IMEG.


8.Report Submission
A)The research leader should compile a research outcome report and submit it to the address in item 6 (“Application Submission”) by 19 April 2019 (Friday). The report format will be sent to the research leader by mid-February 2019.


9.Publication of Research Results
A)If the research leader publishes results obtained from the collaborative research in a paper or other format, submission of one copy of the printed matter, such as a journal article reprint or academic conference presentation abstract to the address in item 6 above.
B)Additionally, please add the following sentence to the acknowledgements section of the paper or other item;
“Supported by the program for Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University.”


10.Handling of Intellectual Property Rights
A)Intellectual property rights of collaborative research will, in principal, belong to the institution which the research leader is affiliated. However, if an intellectual contribution of IMEG faculty members and researchers is recognized, the attribution of intellectual property rights relating to the collaborative research shall be determined by consultation between the research leader’s affiliated institution and IMEG.